drugset / Trial / NCT04432259

Oral Dexamethasone as an Intervention for Postoperative Pain and Nausea Management in Total Knee Arthroplasty

NCT04432259 ↗

Phase 4 Not yet recruiting 300 enrolled Henry Ford Health System
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to determine if oral dexamethasone provides clinically significant improvement in postoperative outcomes, specifically nausea and pain scores.

Timeline

Start
2020-07
Primary completion
2022-06
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 4 mg Oral

Indications